We’ve stocked up our migraine relief kits to the brim, and are still on the hunt for those products that give us the pain relief we desperately need. Whether you found a good product and need another ...

The Food and Drug Administration on Friday approved a new nasal spray drug giant Pfizer says could offer “fast-acting relief” from migraines, launching a new form of medicine onto the market and ...

A batch of over-the-counter migraine relief medication that was shipped by Amazon is being recalled nationwide because it was missing the required manufacturer labels. Pharmaceutical manufacturer ...

The Food and Drug Administration has approved a new medication to treat migraine headaches. Zavzpret (zavegepant) is a nasal spray that can help provide pain relief in as little as 15 minutes in ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. We’ve stocked up our migraine relief kits to the brim, and are ...

Migraine impacts millions worldwide, causing severe pain, nausea, and sensitivity to light and sound. While prescription medications may help, they aren’t the only option. There are some innovative ...

Migraines may occur when the nervous system is overly stimulated. The brain mistakenly sends out pain signals, setting off symptoms of a migraine attack: An intensely throbbing headache, nausea, ...

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology ®, the medical journal of the American ...

A new nasal spray could soon offer Americans “fast-acting relief” from migraines and launch a new form of medicine onto the market, Pfizer announced on Thursday, touting promising results from late ...

Migraine is a complex neurological disease that affects about 1 billion people globally. It is associated with a variety of symptoms that can vary widely from person to person, and even from attack to ...

The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) - the first and only migraine treatment of its kind to be offered in nasal spray.